Cargando…
Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy
Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC(50) of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the...
Autores principales: | Wang, S.-Q., Du, Q.-S., Zhao, K., Li, A.-X., Wei, D.-Q., Chou, K.-C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087620/ https://www.ncbi.nlm.nih.gov/pubmed/16998715 http://dx.doi.org/10.1007/s00726-006-0403-1 |
Ejemplares similares
-
Anti-SARS drug screening by molecular docking
por: Wei, D.-Q., et al.
Publicado: (2006) -
Natural Products as Cathepsin Inhibitors
por: Vidal-Albalat, Andreu, et al.
Publicado: (2016) -
Mechanistic insights into mode of action of novel natural cathepsin L inhibitors
por: Tyagi, Chetna, et al.
Publicado: (2013) -
Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein
por: Power, Helen, et al.
Publicado: (2022) -
Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
por: Meewan, Ittipat, et al.
Publicado: (2022)